Walleye Trading LLC Allogene Therapeutics, Inc. Call Options Transaction History

Walleye Trading LLC

10 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	BUY	$4.92 - $8.21 $79,704 - $133,002	16,200 New	16,200 $80,000
Q3 2022 Nov 14, 2022	BUY	$10.32 - $17.28 $40,248 - $67,392	3,900 New	3,900 $42,000
Q2 2022 Aug 08, 2022	SELL	$6.78 - $12.28 $26,442 - $47,892	-3,900 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$7.65 - $15.29 $29,835 - $59,631	3,900 New	3,900 $36,000
Q3 2021 Nov 15, 2021	SELL	$21.01 - $27.64 $123,959 - $163,076	-5,900 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$23.49 - $35.8 $44,631 - $68,020	-1,900 Reduced 24.36%	5,900 $154,000
Q1 2021 May 17, 2021	BUY	$25.79 - $39.02 $201,162 - $304,356	7,800 New	7,800 $275,000
Q4 2020 Feb 16, 2021	SELL	$25.24 - $43.45 $164,060 - $282,425	-6,500 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$32.38 - $44.96 $58,284 - $80,928	-1,800 Reduced 21.69%	6,500 $245,000
Q2 2020 Aug 14, 2020	BUY	$18.39 - $54.04 $152,637 - $448,532	8,300 New	8,300 $355,000

162

134M

59.4K

113K

Ticker ALLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 143,807,008
Market Cap $326M
Description
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.